TipRanks (Thu, 28-Mar 6:30 AM ET)
Mereo BioPharma Group GAAP EPS of -$0.04
Seeking Alpha News (Wed, 27-Mar 4:49 PM ET)
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
Globe Newswire (Wed, 27-Mar 4:01 PM ET)
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
Globe Newswire (Tue, 5-Mar 7:30 AM ET)
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
Globe Newswire (Mon, 8-Jan 7:00 AM ET)
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.
Mereo Biopharma Group PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol MREO.
As of March 28, 2024, MREO stock price climbed to $3.28 with 819,433 million shares trading.
MREO has a beta of 0.62, meaning it tends to be less sensitive to market movements. MREO has a correlation of 0.01 to the broad based SPY ETF.
MREO has a market cap of $460.00 million. This is considered a Small Cap stock.
In the last 3 years, MREO stock traded as high as $4.36 and as low as $.30.
The top ETF exchange traded funds that MREO belongs to (by Net Assets): HRTS, CANC, APIE.
MREO has outperformed the market in the last year with a price return of +316.3% while the SPY ETF gained +33.7%. MREO has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +35.5% and +2.8%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
MREO support price is $2.88 and resistance is $3.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MREO stock will trade within this expected range on the day.